Vascular Therapies Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

Vascular Therapies General Information

Description

Operator of a biotech company intended to address major unmet clinical needs of patients requiring an AV fistula for dialysis. The company's therapies are used to offer biodegradable collagen implants to treat the problem of vascular anastomosis failure, enabling physicians to improve the outcomes of an arteriovenous fistula and improve patients' lives.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 105 Union Avenue
  • Cresskill, NJ 07626
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 105 Union Avenue
  • Cresskill, NJ 07626
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vascular Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 12-Nov-2025 Completed Out of Business
10. Later Stage VC 18-Feb-2022 Completed Clinical Trials - Phase 3
9. Later Stage VC 28-Jan-2020 Completed Clinical Trials - Phase 3
8. Later Stage VC (Series E2) 10-Oct-2018 Completed Clinical Trials - Phase 3
7. Later Stage VC (Series E) 14-Dec-2016 Completed Clinical Trials - Phase 3
6. Later Stage VC (Series D) 12-Jul-2013 Completed Clinical Trials - Phase 3
5. Later Stage VC 01-Dec-2012 Completed Clinical Trials - Phase 3
4. Seed Round 09-Jun-2011 Completed Clinical Trials - Phase 3
3. Grant 01-Jan-2009 $244K $7.49M Completed Startup
2. Angel (individual) 17-Oct-2005 $7.49M $7.49M Completed Startup
To view Vascular Therapies’s complete valuation and funding history, request access »

Vascular Therapies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E2
Series E1
Series D
Series C2
Series C1
Series B4
Series B3
Series B2
Series B1 169,000 $0.001000 8% $0.01 $0.01 1x $0.01 0.05%
Series A4 316,667 $0.001000 8% $3 $3 1x $3 0.99%
To view Vascular Therapies’s complete cap table history, request access »

Vascular Therapies Patents

Vascular Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025250493-A1 Product to treat or prevent stenosis in a blood vessel Pending 31-May-2024
WO-2025250493-A9 Product to treat or prevent stenosis in a blood vessel Pending 31-May-2024
WO-2024119179-A1 Unitary product for addressing arteriovenous fistula stenosis Inactive 03-Dec-2022
JP-2019150584-A Device and method for preventing constriction at anastomotic site Pending 27-Jan-2010
EP-2528537-A1 Device and method for preventing stenosis at an anastomosis site Inactive 27-Jan-2010 A61F2/064
To view Vascular Therapies’s complete patent history, request access »

Vascular Therapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vascular Therapies FAQs

  • When was Vascular Therapies founded?

    Vascular Therapies was founded in 2001.

  • Where is Vascular Therapies headquartered?

    Vascular Therapies is headquartered in Cresskill, NJ.

  • What is the size of Vascular Therapies?

    Vascular Therapies has 7 total employees.

  • What industry is Vascular Therapies in?

    Vascular Therapies’s primary industry is Therapeutic Devices.

  • Is Vascular Therapies a private or public company?

    Vascular Therapies is a Private company.

  • What is Vascular Therapies’s current revenue?

    The current revenue for Vascular Therapies is .

  • How much funding has Vascular Therapies raised over time?

    Vascular Therapies has raised $112M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process